1. Home
  2. SUJA vs BCYC Comparison

SUJA vs BCYC Comparison

Compare SUJA & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Suja Life Inc. Class A Common Stock

SUJA

Suja Life Inc. Class A Common Stock

N/A

Current Price

$6.38

Market Cap

215.3M

ML Signal

N/A

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

N/A

Current Price

$3.06

Market Cap

256.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SUJA
BCYC
Founded
2012
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.3M
256.5M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
SUJA
BCYC
Price
$6.38
$3.06
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
★ $12.40
$9.17
AVG Volume (30 Days)
170.5K
★ 378.8K
Earning Date
11-10-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.99
N/A
Revenue Next Year
$7.41
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.59
$3.07
52 Week High
$12.42
$7.83

Technical Indicators

Market Signals
Indicator
SUJA
BCYC
Relative Strength Index (RSI) 23.71 33.35
Support Level $5.59 N/A
Resistance Level $10.96 $3.94
Average True Range (ATR) 0.79 0.18
MACD -0.45 -0.06
Stochastic Oscillator 5.20 2.52

Price Performance

Historical Comparison
SUJA
BCYC

About SUJA Suja Life Inc. Class A Common Stock

Suja Life Inc operates a beverage platform focused on producing and selling products such as cold-pressed juices, wellness shots, and functional sodas. Its portfolio includes brands such as Suja Organic, Vive Organic, and Slice. The Company operates and manages its business in two operating segments, which are also reportable segments: i) Suja Core: It produces and distributes cold-pressed fresh juice and cold-pressed juice shots. ii) Emerging Brands: It consists of recently acquired or launched brands and products that are still in the early stages of revenue scale, market development, or distribution build-out. The majority of revenue is derived from Suja Core.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: